PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL TO SUPPORT OPHTHALMIC SUSPENSIONS DEVELOPMENT.

被引：0
|
作者：
Le Merdy, M. [1 ]
Fan, J. [1 ]
Babiskin, A. H. [1 ]
Zhao, L. [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PBPK-011
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [31] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING FOR PREGNANCY
    Liu, X.
    Leong, R.
    Buckart, G.
    Dallmann, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S117 - S117
  • [32] An introduction to physiologically-based pharmacokinetic models
    Upton, Richard N.
    Foster, David J. R.
    Abuhelwa, Ahmad Y.
    PEDIATRIC ANESTHESIA, 2016, 26 (11) : 1036 - 1046
  • [33] Physiologically-based pharmacokinetic analysis of grepafloxacin
    Nakajima, Y
    Hattori, K
    Shinsei, M
    Matsunaga, N
    Iizasa, H
    Sasabe, H
    Akiyama, H
    Miyamoto, G
    Nakashima, E
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (09) : 1077 - 1083
  • [34] Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development
    Zhao, Sherry
    Gockenbach, Mary
    Grimstein, Manuela
    Sachs, Hari Cheryl
    Mirochnick, Mark
    Struble, Kimberly
    Belew, Yodit
    Wang, Jian
    Capparelli, Edmund, V
    Best, Brookie M.
    Johnson, Tamara
    Momper, Jeremiah D.
    Maharaj, Anil R.
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [35] DEVELOPMENT OF A PEDIATRIC BRAIN PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL IN CHILDREN WITH AND WITHOUT MENINGITIS.
    Verscheijden, L. F. M.
    Koenderink, J. B.
    Allegaert, K.
    de Wildt, S. N.
    Russel, F. G. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S74 - S74
  • [36] Physiologically-based pharmacokinetic model of topical intravaginal HIV prevention
    Kay, Katherine
    Rohan, Lisa C.
    Shah, Dhavalkumar
    Bies, Robert
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S88 - S88
  • [37] Physiologically-based pharmacokinetic model for predicting blood and tissue concentrations
    Zhu, Leo
    Pei, William
    DiCiano, Patricia
    Brands, Bruna
    Wickens, Christine M.
    Le Foll, Bernard
    Kwong, Bronsen
    Parashar, Megha
    Sivananthan, Atchu
    Mahadevan, Radhakrishnan
    COMPUTERS & CHEMICAL ENGINEERING, 2021, 154
  • [38] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF METOCLOPRAMIDE IN SPECIAL POPULATIONS.
    Silva, L.
    Diniz, A.
    Martins, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S10 - S10
  • [39] Physiologically-based pharmacokinetic (PBPK) model to describe the disposition of pyronaridine
    Diep, John K.
    Lingerfelt, Mary A.
    Ekins, Sean
    Rao, Gauri G.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S34 - S34
  • [40] Development of a physiologically-based pharmacokinetic model for the study of 2-methylimidazole kinetics.
    Easterling, M
    Portier, CJ
    TOXICOLOGICAL SCIENCES, 2003, 72 : 179 - 179
12345